BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 927 filers reported holding BAXTER INTL INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,420,836 | +4799.4% | 37,648 | +10328.8% | 0.02% | – |
Q4 2020 | $29,000 | -34.1% | 361 | -29.4% | 0.00% | -100.0% |
Q2 2020 | $44,000 | +1000.0% | 511 | +922.0% | 0.00% | – |
Q1 2020 | $4,000 | -100.0% | 50 | -100.0% | 0.00% | -100.0% |
Q4 2019 | $13,682,000 | +554.3% | 163,617 | +584.4% | 0.21% | +517.6% |
Q3 2019 | $2,091,000 | -63.1% | 23,905 | -65.5% | 0.03% | -63.0% |
Q2 2019 | $5,667,000 | +369.9% | 69,196 | +366.3% | 0.09% | +283.3% |
Q1 2019 | $1,206,000 | +21.1% | 14,838 | -1.9% | 0.02% | +9.1% |
Q4 2018 | $996,000 | -71.2% | 15,125 | -71.6% | 0.02% | -73.2% |
Q1 2018 | $3,462,000 | -78.1% | 53,222 | -78.2% | 0.08% | -79.8% |
Q4 2017 | $15,806,000 | +4.6% | 244,531 | +1.5% | 0.41% | +11.8% |
Q3 2017 | $15,116,000 | -16.5% | 240,889 | -19.4% | 0.36% | -23.1% |
Q2 2017 | $18,100,000 | +0.8% | 298,964 | -13.6% | 0.47% | 0.0% |
Q1 2017 | $17,949,000 | +25.4% | 346,105 | +7.2% | 0.47% | +11.1% |
Q4 2016 | $14,317,000 | +53.3% | 322,909 | +64.5% | 0.42% | +2.7% |
Q3 2016 | $9,342,000 | +9432.7% | 196,280 | +9016.6% | 0.41% | +8180.0% |
Q2 2016 | $98,000 | -98.5% | 2,153 | -97.7% | 0.01% | -97.6% |
Q2 2013 | $6,479,000 | – | 93,536 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |